Ty Gluckman, MD: The Staggering Cost of Cardiovascular Disease Prevention - MD Magazine

At the 2022 ASPC annual meeting, Dr. Gluckman highlights the overall impact of the economic cost of cardiovascular disease and the role of prevention.

The role of prevention is paramount in treating cardiovascular disease (CVD), but the economic impact of the treatment is staggering. Data suggest an excess of $200 billion in direct costs is spent … [+2544 chars]

full article...